Correlation Between Acrivon Therapeutics, and AnaptysBio
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and AnaptysBio, you can compare the effects of market volatilities on Acrivon Therapeutics, and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and AnaptysBio.
Diversification Opportunities for Acrivon Therapeutics, and AnaptysBio
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Acrivon and AnaptysBio is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and AnaptysBio go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and AnaptysBio
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 0.57 times more return on investment than AnaptysBio. However, Acrivon Therapeutics, Common is 1.77 times less risky than AnaptysBio. It trades about -0.19 of its potential returns per unit of risk. AnaptysBio is currently generating about -0.18 per unit of risk. If you would invest 803.00 in Acrivon Therapeutics, Common on August 25, 2024 and sell it today you would lose (148.00) from holding Acrivon Therapeutics, Common or give up 18.43% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. AnaptysBio
Performance |
| Timeline |
| Acrivon Therapeutics, |
| AnaptysBio |
Acrivon Therapeutics, and AnaptysBio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and AnaptysBio
The main advantage of trading using opposite Acrivon Therapeutics, and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. HCW Biologics | Acrivon Therapeutics, vs. Scpharmaceuticals | Acrivon Therapeutics, vs. Milestone Pharmaceuticals |
| AnaptysBio vs. Crinetics Pharmaceuticals | AnaptysBio vs. Rhythm Pharmaceuticals | AnaptysBio vs. Kura Oncology | AnaptysBio vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |